PDS Biotechnology Corp (PDSB)
$0.22+$0.00 (+0.00%) Today
Latest PDSB Insider Trades
Frank Bedu-Addo - OfficerGrant or award548,782 sh
Frank Bedu-Addo - Officer
Gregory Conn - Officer
Lars Boesgaard - Officer
Spencer D. Brown - Officer
Stephan Toutain - Officer
Gregory Gene Freitag
Ilian IlievPDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
No Form 4 activity for PDSB in the last 90 days.
19 Form 4 filings on record, the earliest from Jun 11, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Frank Bedu-Addo - Officer | Grant or award | Employee Stock Option (Right to Buy) | 548,782 | $0.00 | - | |
| Gregory Conn - Officer | Grant or award | Employee Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Kirk V. Shepard - Officer | Grant or award | Employee Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Lars Boesgaard - Officer | Grant or award | Employee Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Spencer D. Brown - Officer | Grant or award | Employee Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Stephan Toutain - Officer | Grant or award | Employee Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Gregory Gene Freitag | Grant or award | Employee Stock Option (Right to Buy) | 54,876 | $0.00 | - | |
| Ilian Iliev | Grant or award | Employee Stock Option (Right to Buy) | 54,876 | $0.00 | - | |
| Kamil Ali-Jackson | Grant or award | Employee Stock Option (Right to Buy) | 54,876 | $0.00 | - | |
| Otis W. Brawley | Grant or award | Employee Stock Option (Right to Buy) | 54,876 | $0.00 | - | |
| Stephen C. Glover | Grant or award | Employee Stock Option (Right to Buy) | 54,876 | $0.00 | - | |
| Spencer D. Brown - Officer | Grant or award | Employee Stock Option (Right to Buy) | 56,000 | $0.00 | - | |
| Spencer D. Brown - Officer | Grant or award | Employee Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Gregory Conn - Officer | Grant or award | Employee Stock Option (Right to Buy) | 46,648 | $0.00 | - | |
| Gregory Conn - Officer | Grant or award | Employee Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Frank Bedu-Addo - Officer | Grant or award | Employee Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| Frank Bedu-Addo - Officer | Grant or award | Employee Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Kirk V. Shepard - Officer | Grant or award | Employee Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Stephan Toutain - Officer | Grant or award | Employee Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Lars Boesgaard - Officer | Grant or award | Employee Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Stephen C. Glover | Grant or award | Employee Stock Option (Right to Buy) | 22,700 | $0.00 | - | |
| Otis W. Brawley | Grant or award | Employee Stock Option (Right to Buy) | 22,700 | $0.00 | - |
PDS Biotechnology Corp (PDSB) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-03. The full record for PDSB runs to 19 Form 4 filings, the earliest from 2025-06-11. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of PDSB were filed in the last 90 days.
No insider sales of PDSB were filed in the last 90 days.
This page tracks PDSB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PDSB to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
